Physician profile
Alyssa Einstein
NPI 1417710286
$3,313.86
in general payments reported to CMS, 2019-2025
20 companies · $2,114 in 2025
The $2,114 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,200 · 2025: $2,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,115 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,114.87 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $758.21 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $587.17 | 2025 | Dupixent |
| Janssen Biotech, INC. | $340.49 | 2024-2025 | Tremfya |
| Abbvie INC. | $328.22 | 2024-2025 | |
| Organon LLC | $204.89 | 2025 | Vtama |
| Dermavant Sciences, INC. | $155.32 | 2024 | Vtama |
| Ucb, INC. | $147.69 | 2024-2025 | Bimzelx |
| Amgen INC. | $89.08 | 2024-2025 | Otezla, Otezla |
| Lilly USA, LLC | $87.71 | 2024-2025 | Ebglyss, Taltz |
| Almirall LLC | $76.76 | 2024-2025 | Seysara |
| Arcutis Biotherapeutics, INC. | $75.87 | 2025 | Zoryve |
| Leo Pharma INC. | $71.65 | 2025 | Adbry, Anzupgo |
| Novartis Pharmaceuticals Corporation | $71.54 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $71.38 | 2024-2025 | |
| Galderma Laboratories, L.P. | $70.83 | 2024-2025 | Nemluvio |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $52.18 | 2024 | Sotyktu |
| Pfizer INC. | $49.59 | 2025 | |
| Mayne Pharma Commercial LLC | $29.12 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.23 | 2024 | Spevigo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.93 | 2025 | Jublia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Einstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.